Biotech · Private company · Brooklyn, NY, US
Phoenix Nest
Track this companyFree. Adds Phoenix Nest to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- Natural History to Assess Disease in Patients With MPS IIICNOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07712003 · fetched Nov 12, 2026
- Natural History Study of Participants With Sanfilippo Syndrome Type IIICRECRUITING · started Nov 10, 2024ClinicalTrials.gov NCT05825131 · fetched Nov 12, 2026
- A Natural History Study of Sanfilippo Syndrome Type DCOMPLETED · started Jan 22, 2023ClinicalTrials.gov NCT05648851 · fetched Nov 12, 2026
NIH awards5
- Manufacturing and Analytical Development for JLK-247 Gene TherapyFiscal year 2026 · $1.5MNIH RePORTER 1R44NS147802-01 · fetched Nov 12, 2026
- Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients.Fiscal year 2025 · $1.1MNIH RePORTER 5R44NS137892-02 · fetched Nov 12, 2026
- Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients.Fiscal year 2024 · $881.7KNIH RePORTER 1R44NS137892-01 · fetched Nov 12, 2026
- Evaluation of Clinical Outcome Assessment (COA) and Potential Biomarkers to Facilitate Interventional Trial for Mucopolysaccharidosis IIID PatientsFiscal year 2024 · $100KNIH RePORTER 3UB1NS122644-04S1 · fetched Nov 12, 2026
- Evaluation of Clinical Outcome Assessment (COA) and Potential Biomarkers to Facilitate Interventional Trial for Mucopolysaccharidosis IIID PatientsFiscal year 2024 · $798.3KNIH RePORTER 5UB1NS122644-04 · fetched Nov 12, 2026